Tenet Healthcare (THC) Status update summary
Event summary combining transcript, slides, and related documents.
Status update summary
2 Feb, 2026Transaction overview
Closed an accretive asset sale involving Conifer's revenue cycle management contract with CommonSpirit, valued at $2.65 billion through cash, liability reduction, and additional equity acquisition.
CommonSpirit will pay $1.9 billion over three years, with an initial $540 million in Q1 2026 and three annual installments of $453 million each in 2027, 2028, and 2029; $540 million is offset by Tenet's redemption payment.
Conifer will continue providing services to CommonSpirit through 2026 under existing financial terms.
The transaction results in Tenet gaining full strategic control of Conifer and an increase of $305 million in additional paid-in capital.
The transaction reduces redeemable non-controlling interest and other liabilities by $885 million.
Financial and operational impacts
2025 adjusted EBITDA is expected at the upper end of the $4.47–$4.57 billion guidance range, driven by strong same-store revenues and disciplined expense management.
NCI expense will decrease by approximately $100 million in 2026 as Tenet recognizes all Conifer economics.
The deal delivers an approximate 14x multiple on impacted 2025 adjusted EBITDA less NCI.
The transaction is expected to strengthen cash flow and support capital deployment priorities, including share repurchases, M&A in ambulatory care, and organic growth investments.
Actual results may differ from preliminary estimates as the financial statement close process is not yet complete.
Strategic rationale and future direction
Full ownership enables Tenet to accelerate investments in automation, AI, and offshoring to enhance Conifer's efficiency and competitiveness.
Conifer's innovation focus includes automating workflows, AI-driven denials management, and advanced analytics to reduce cost to collect and improve yield.
The company plans to redeploy resources and pursue growth opportunities as the CommonSpirit contract winds down.
No constraints were cited from the prior joint venture; future investments and decisions will be solely under Tenet's control.
The transition is structured to be collaborative, supporting CommonSpirit’s insourcing strategy and Conifer’s continued innovation.
Latest events from Tenet Healthcare
- AI-driven efficiencies and targeted investments fuel growth in high-acuity care and ambulatory services.THC
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Q4 2025 delivered double-digit EBITDA and EPS growth, with a strong 2026 outlook.THC
Q4 202511 Feb 2026 - Q2 2024 net income and EBITDA surged, with FY 2024 outlook and buybacks increased.THC
Q2 20243 Feb 2026 - Deleveraging and disciplined growth drive strong performance in hospitals and ambulatory services.THC
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Q3 net income soared to $472M, guidance raised, and Ambulatory Care led robust growth.THC
Q3 202418 Jan 2026 - Operational improvements, strong demand, and portfolio optimization drive growth outlook.THC
UBS Global Healthcare Conference14 Jan 2026 - Q4 and FY 2024 delivered margin growth, deleveraging, and strong ambulatory expansion.THC
Q4 20248 Jan 2026 - Q1 2025 EBITDA up 14%, margin expansion, strong cash flow, and $348M in buybacks.THC
Q1 202525 Dec 2025 - High-acuity services and ASC growth drive strong financials amid stable policy and labor trends.THC
Barclays 27th Annual Global Healthcare Conference20 Dec 2025